Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Monopar Therapeutics (MNPR) EPS (Basic): 2016-2019

Historic EPS (Basic) for Monopar Therapeutics (MNPR) over the last 4 years, with Dec 2019 value amounting to -$0.45.

  • Monopar Therapeutics' EPS (Basic) fell 30.00% to -$0.13 in Q4 2019 from the same period last year, while for Dec 2019 it was -$0.46, marking a year-over-year decrease of 39.39%. This contributed to the annual value of -$0.45 for FY2019, which is 28.57% down from last year.
  • Latest data reveals that Monopar Therapeutics reported EPS (Basic) of -$0.45 as of FY2019, which was down 28.57% from -$0.35 recorded in FY2018.
  • In the past 5 years, Monopar Therapeutics' EPS (Basic) registered a high of -$0.35 during FY2018, and its lowest value of -$1.89 during FY2017.
  • Over the past 3 years, Monopar Therapeutics' median EPS (Basic) value was -$0.45 (recorded in 2019), while the average stood at -$0.90.
  • As far as peak fluctuations go, Monopar Therapeutics' EPS (Basic) slumped by 194.44% in 2017, and later surged by 81.48% in 2018.
  • Over the past 4 years, Monopar Therapeutics' EPS (Basic) (Yearly) stood at -$0.64 in 2016, then slumped by 194.44% to -$1.89 in 2017, then skyrocketed by 81.48% to -$0.35 in 2018, then dropped by 28.57% to -$0.45 in 2019.